ENGLISH
|
HINDI
APPS
iPhone
|
iPad
|
BlackBerry
|
Android
Nokia
Windows
Network18
Quotes
Quotes
NAVs
News
Messages
People
Notices
Videos
All
FEEDBACK
Facebook
Follow @moneycontrolcom on Twitter
CNBC TV 18
moneycontrol
News
Markets
Mutual Funds
IPO
Commodities
Wealth
Portfolio
Messages
My TV
Tax
Fixed Income
Property
SME
CNBC-TV18
Home
Business
General News
Market Trends
Stocks
Fund News
Personal Finance
Corporate Strategy
Lifestyle
Politics
Legal
Master Your Money
Share
>
Share
Tweet
Share on Tumblr
Pantoprazole Tablets
News »
latest
by relevance
Jubilant receives USFDA approval for Pantoprazole tablets
Sep 07, 2011 at 22:38 | Source:
PTI
Jubilant Life Sciences today said it has received the US health regulator's approval for the launch of Pantoprazole Delayed Release Tablets 20 mg and 40mg.
Jubilant Life Sciences gets US FDA nod for anti-ulcer drug
Sep 07, 2011 at 15:28 | Source:
Moneycontrol.com
Pharma company Jubilant Life Sciences has received US Food and Drug Administration (US FDA) approval for its abbreviated new drug application for Pantoprazole Sodium delayed release tablets in 20 mg and 40 mg strength.
Sun Pharma launches generic Protonix Tablets
Jan 30, 2008 at 11:42
Sun Pharma launches generic Protonix Tablets
Pantoprazole may aid Sun Pharma gross up to $150m
Sep 11, 2007 at 16:30
Sun Pharma has received USFDA nod to market Pantoprazole tablets, which is the generic version of Wyeth's Protonix. Pantoprazole is an anti-ulcer drug with a US market of over USD 2.5 billion.
Sun Pharma announces USFDA approval to mkt Protonix tablets
Sep 11, 2007 at 11:20
Sun Pharma announces USFDA approval to market generic Protonix tablets. Company gets its first 180 day marketing exclusivity on a first-to-file ANDA with para IV certification
Sun Pharma undecided on Pantoprazole launch
Sep 11, 2007 at 10:38
Sun Pharma has received USFDA nod to market Pantoprazole tablets. Pantoprazole is an anti-ulcer drug, with a US market of over USD1 billion. This drug is the generic version of Wyeth's Protonix.
Jubilant receives USFDA approval for Pantoprazole tablets
Sep 07, 2011 at 22:38 | Source:
PTI
Jubilant Life Sciences today said it has received the US health regulator's approval for the launch of Pantoprazole Delayed Release Tablets 20 mg and 40mg.
Jubilant Life Sciences gets US FDA nod for anti-ulcer drug
Sep 07, 2011 at 15:28 | Source:
Moneycontrol.com
Pharma company Jubilant Life Sciences has received US Food and Drug Administration (US FDA) approval for its abbreviated new drug application for Pantoprazole Sodium delayed release tablets in 20 mg and 40 mg strength.
Sun Pharma launches generic Protonix Tablets
Jan 30, 2008 at 11:42
Sun Pharma launches generic Protonix Tablets
Sun Pharma gets USFDA nod for Pantoprazole: Srcs
Sep 11, 2007 at 09:40
Sun Pharma has received USFDA nod to market Pantoprazole tablets, reports NW18. Pantoprazole is an anti-ulcer drug, with a US market of over USD1 billion. This drug is the generic version of Wyeth's Protonix.
Sun Pharma undecided on Pantoprazole launch
Sep 11, 2007 at 10:38
Sun Pharma has received USFDA nod to market Pantoprazole tablets. Pantoprazole is an anti-ulcer drug, with a US market of over USD1 billion. This drug is the generic version of Wyeth's Protonix.
Pantoprazole may aid Sun Pharma gross up to $150m
Sep 11, 2007 at 16:30
Sun Pharma has received USFDA nod to market Pantoprazole tablets, which is the generic version of Wyeth's Protonix. Pantoprazole is an anti-ulcer drug with a US market of over USD 2.5 billion.
Videos »
Sun Pharma undecided on Pantoprazole launch
Pantoprazole may aid Sun Pharma gross up to $150m
more »
Photos »
/
Follow moneycontrol.com
Facebook
Twitter
Google Plus
RSS
Wap SMS
SMS
Alert
iPad
iPhone
Blackberry
OVI
Android
Window
